I-Mab to Release 1H 2024 Financial Results on August 28, 2024

Rhea-AI Summary

I-Mab (NASDAQ: IMAB), a US-based global biotech company focused on developing immunotherapies for cancer treatment, has announced it will release its 1H 2024 financial results on August 28, 2024. The company will host a conference call and webcast at 8:00 AM ET on the same day to discuss financial results, pipeline progress, and recent business highlights for the half year ended June 30, 2024.

Investors and analysts can join the conference call via domestic (1-877-407-0784) or international (1-201-689-8560) dial-in numbers, using the Conference ID: 13747695. A webcast link is also provided. The Call me™ link will be active 15 minutes before the scheduled start time. A replay of the call will be available on the I-Mab website's Investor Relations page for 6 months.

Conference call to discuss financial results and recent business highlights to take place on Wednesday, August 28, 2024, at 8:00 AM ET

ROCKVILLE, Md., Aug. 14, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a US-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced that it plans to host a conference call and webcast on Wednesday, August 28, 2024, 8:00 AM ET to discuss financial results, pipeline progress and recent business highlights for the half year ended June 30, 2024.

I-Mab Conference Call and Webcast Information:

Investors and analysts are invited to join the conference call at 8:00 AM ET on August 28, 2024, via:

• Domestic Dial-in: 1-877-407-0784
• International Dial-in: 1-201-689-8560
• Conference ID: 13747695
• Webcast: please click here

Note that Participants can use Guest dial-in #s above and be answered by an operator OR click the Call me™ link for instant telephone access to the event.

The Call me™ link will be made active 15 minutes prior to the scheduled start time.

A webcast of the call will also be available on the I-Mab website, on the Upcoming Events section of the Investor Relations page, available by clicking here. A replay of the call will be accessible under the Past Events section of the Investor Relations page and will be archived for 6 months.

About I-Mab

I-Mab (NASDAQ: IMAB) is a US-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer.

I-Mab has established operations in Rockville, Maryland. For more information, please visit https://www.i-mabbiopharma.com and follow us on LinkedIn and X.

I-Mab Contacts

Investors & Media

Tyler Ehler

Senior Director, Investor Relations

IR@imabbio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/i-mab-to-release-1h-2024-financial-results-on-august-28-2024-302221660.html

SOURCE I-Mab Biopharma

FAQ

When will I-Mab (IMAB) release its 1H 2024 financial results?

I-Mab (IMAB) will release its 1H 2024 financial results on August 28, 2024.

What time is I-Mab's (IMAB) conference call for 1H 2024 results?

I-Mab's (IMAB) conference call for 1H 2024 results is scheduled for 8:00 AM ET on August 28, 2024.

How can investors join I-Mab's (IMAB) 1H 2024 results conference call?

Investors can join I-Mab's (IMAB) 1H 2024 results conference call via domestic dial-in (1-877-407-0784), international dial-in (1-201-689-8560), or through a provided webcast link.

What is the Conference ID for I-Mab's (IMAB) 1H 2024 results call?

The Conference ID for I-Mab's (IMAB) 1H 2024 results call is 13747695.